EVAXION BIOTECH A S - ADS (EVAX)

CUSIP: 29970R105

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / ADS
Total 13F shares
437,168
Share change
-33,873
Total reported value
$307,330
Put/Call ratio
3%
Price per share
$0.69
Number of holders
8
Value change
-$33,919
Number of buys
4
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 29970R105?
CUSIP 29970R105 identifies EVAX - EVAXION BIOTECH A S - ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EVAXION BIOTECH A S - ADS (EVAX) as of Q4 2023

As of 31 Dec 2023, EVAXION BIOTECH A S - ADS (EVAX) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 437,168 shares. The largest 8 holders included LM Advisors LLC, Beacon Capital Management, LLC, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, JPMORGAN CHASE & CO, RHUMBLINE ADVISERS, GROUP ONE TRADING, L.P., and UBS Group AG. This page lists 8 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.